Introduction
All human cells require folates intracellularly for enzyme reactions that are crucial to the synthesis of deoxyribonucleic acid (1) . Recently, we established that specific, high affinity, externally-oriented, membrane-associated folate-binding proteins (FBPs)' on the surface of malignant human nasopharyngeal carcinoma (KB) cells act as specific transport proteins in the cellular uptake of folates (2) . However, little is known about the existence or function of similar proteins in normal human Earlier, we identified by indirect immunofluorescence studies that immunologically similar proteins to human placental folate receptors (PFR) were present on circulating human erythrocytes (3) . Since erythrocytes have a 30-fold higher intracellular folate concentration than serum (1), we suggested that this gradient could be mediated by specific folate transport proteins (3) . Although subsequent investigations identified that human erythrocyte membranes (4), ghosts and intact cells (5) , contained FBPs that had similar characteristics of folate binding as KB cell FBPs (2), the magnitude of folate uptake in circulating erythrocytes (in contrast to KB cells) was much lower and not consistent with a physiologically significant specific FBP-mediated uptake system (5a). Furthermore, the majority of erythrocyte FBPs identified by a specific radioimmunoassay to PFR (6) were nonfunctional in that they did not bind radiolabeled folate (5a). These studies suggested that the higher intracellular folate content in the erythrocyte was probably achieved at an earlier stage in development. Using in vitro hematopoietic progenitor cell assays, we asked the following questions: (i) Is the development of erythroid progenitor and precursor cells dependent on the functional integrity of specific folate receptors? and (ii) Can perturbation of specific folate receptors on these cells lead to qualitative and/or quantitative changes consistent with folate deficiency? Our studies appear to support the conclusion that specific folate receptors mediate folate uptake in normal human marrow cells in vitro.
Methods
Iscove's modified Dulbecco's medium (IMDM) containing 4 mg folic acid per liter, and preservative-free sodium heparin were obtained from Gibco, Grand Island, NY. Partially purified human urinary erythropoietin (72 U/mg of protein) was obtained from Toyobo Co., New York, NY. Fetal calf serum and rabbit preimmune serum were purchased from HyClone Laboratories, Inc., Logan, UT, whereas 125I1 labeled folic acid ( The culture plates were incubated at 370C in a light-protected, humidified atmosphere of 5% CO2 in air. BFU-E were scored after 14 d using standard criteria (8, 9) . To determine the number of cells per erythroid colony, plates containing enumerated numbers of erythroid bursts were harvested into sterile PBS (10 mM potassium phosphate, pH 7.5, containing 150 mM NaCl) and the cells sedimented at 1,000 g for 10 min at 22°C. The resulting supernatant was aspirated, discarded, and the sedimented cells were washed with 50 vol of PBS for three additional centrifuge-wash cycles, as described above. They were finally resuspended in 0.5 ml PBS and total erythroid cell counts were determined manually with a hemocytometer. Based on the number of cells derived from a known number of erythroid bursts per plate, the approximate number of erythroid cells per erythroid burst was determined. Erythroid colonies were also directly plucked from methylcellulose cultures with a sterile tapered pasteur pipette under direct microscopic visualization, and cells (-10,000) were resuspended in 100 Ml PBS and transferred to slides using a centrifuge (Shandon Cytocentrifuge II; Shandon Southern Instruments Inc., Sewickley, PA) at 750 rpm for 5 min. After drying and fixation with methanol, the stained cells were observed for morphological changes. Orthochromatic normoblast cell sizing was performed using a digital filar eyepiece (Los Angeles Scientific Instrument Co., Los Angeles, CA) adaptable to a standard light microscope. Also, the number of nuclei per cell was determined in each group of cells described above.
Assay for endogenous intracellular folate. Erythroid bursts were plucked from culture plates containing cells incubated with either rabbit preimmune or antihuman PFR antiserum. The percentage of erythroid cells in these bursts were > 98%. Cells from 14 antisera and 18 preimmune sera-treated plates were separately pooled, washed with 100 vol of PBS for two centrifuge-wash cycles as described above, resuspended in 5 ml PBS, and the number of cells/ml determined. The cells were subsequently frozen at -70°C in dry ice-acetone and thawed at 22°C in a water bath for two cycles to lyse the cells. The mixture was centrifuged at 30,000 g for 30 min at 4°C in a centrifuge (model J-2 1; Beckman Instruments), and the supernatant containing released intracellular material was filtered through O.22Am Millex-GV filters to retain particulate material. The filtrate was subsequently assayed for folate content, as previously described (7, 10, 1 1). The standard curve for the radioisotope dilution assay was based on the ability of known concentrations of unlabeled folic acid (pteroylglutamate [PteGlu] ) to competitively inhibit the binding of '25I-labeled folic acid (histamine derivative) to bovine FBP (present as a contaminant in (3-lactoglobulin) . Briefly, a final reaction volume of 1 ml contained 160 Mumol borate-KOH, pH 9.5, 2 Amol dithiothreitol, 10 Amol 2-mercaptoethanol, 5 fmol '25I-labeled folic acid (histamine derivative), and increasing concentrations of unlabeled PteGlu (0.05-5 pmol) or the sample to be measured for endogenous folate. The mixtures were boiled at 1000C and cooled at 220C and /3-lactoglobulin (4 Mg) was added to each tube (Eppendorf Microfuge; Brinkmann Instruments Inc., Westbury, NY). After incubation for 30 min at 220C, 0.8 mg dextran-coated charcoal was added and the mixtures were incubated another 10 min at 220C. The samples were subsequently centrifuged in a centrifuge (model 59A Micro-Centrifuge, Fisher Scientific Co.) for 2 min at top speed, and 0.5 ml of each supernatant (containing radiolabeled folate-bound FBP) was counted for radioactivity. The radioactivity ofthe supernatant in the sample was directly compared with that of the standard curve obtained with PteGlu. Under the conditions of the assay, both PteGlu as well as 5-methyltetrahydrofolate bind bovine FBPs with comparably high affinity (10) . This assay however fails to detect other folate forms (such as 5-formyltetrahydrofolate) that have lower affinity and consequently lower ability to displace '251I-labeled folic acid (histamine derivative) from bovine FBP relative to PteGlu. The assay had an upper limit of sensitivity of 100 fmol and a lower limit of sensitivity of 5 pmol PteGlu. Each sample for folate analysis was assayed in triplicate at various dilutions, and the concentration of folate in the unknown sample that was well within the standard curve was determined. Based on the number of cells in each sample (treated with preimmune and immune serum) and the results from the assay for endogenous folate (released from these cells), the concentration of intracellular folate per cell was determined.
Statistical analysis. Each of the experiments described above were carried out on three or more occasions using bone marrow cells from different human subjects. The results of cloning efficiency, and morphology of erythroid progenitor cells in the presence of rabbit preimmune and immune serum was quantitatively and qualitatively comparable with < 10% variation. The data for BFU-E-derived colonies is expressed as the mean±SD from quadruplicate values ofcolony assays, and levels of statistical significance were determined using the student's t test. The values for endogenous folate performed in triplicate in preimmune and immune serum-treated cells are expressed as the mean±SD from cells of one volunteer. In two subsequent experiments with bone marrow cells from different volunteers, the values for endogenous folate did not significantly differ (< 10% variation) from one another in immune and preimmune serum-treated cells.
Results
Rabbit preimmune serum resulted in slight but insignificant augmentation of formation of erythroid bursts in vitro compared with control cells grown in the absence of rabbit serum. Incubation of cells with increasing concentrations of antihuman PFR antiserum, however, resulted in a progressive increase in the number of erythroid bursts over concomitant controls assayed in the presence of preimmune serum alone (Fig. 1) . With complete replacement of preimmiine serum by antihuman PFR antiserum, there was a 3.9-fold greater number of BFU-E-derived colonies per plate as compared with controls containing preimmune serum alone. Also, the erythropoietic bursts developed in the presence of antihuman PFR antiserum were larger and contained -twofold greater number of cells (6,100±300 cells/BFU-E-derived colony) as compared with controls developed in the presence of preimmune serum (3,450±150 cells/BFU-E-derived colony).
Analysis of Wright-Giemsa stained cells from BFU-E-derived colonies assayed in the presence of antihuman PFR antiserum, but not in preimmune serum, revealed findings that were consistent with morphological changes associated with megaloblastic erythropoiesis (Fig. 2 top, middle, bottom) . This was best appreciated in orthochromatic normoblasts that contained fine nuclear chromatin that was more characteristic of nuclei from proerythroblasts and early normoblasts ( Fig. 2   bottom) ; also, many such cells contained evidence of dyseryth- ropoiesis with two or more nuclei per cell that were joined by fine internuclear bridging material (Fig. 2 middle) . Also, there was marked retardation of nuclear maturity and pyknosis in antiserum-treated cells; these morphological findings are consistent with functional nuclear-cytoplasmic asynchrony, which is the hallmark of megaloblastic erythropoiesis (1).
To Taken together, these studies strongly suggest that specific folate receptors play a major functional role in the accumulation of folate in erythroid progenitor cells in vitro.
Discussion
Circulating human erythrocytes are unique among human cells in that they have a single external plasma membrane without any intracellular organelles. The fact that these cells contain a 30-fold higher intracellular folate content as compared with that in serum has remained unexplained. The major form of serum folate is 5-methyltetrahydrofolate (monoglutamate), whereas intracellular folates are predominantly polyglutamated (12) . The enzyme responsible for polyglutamation of folate, PteGlu synthetase, is however absent in mature cells (13) . This suggests that the existing folate in mature cells was taken up as 5-methyltetrahydrofolate and subsequently polyglutamated in (immature) erythroid precursors within the bone marrow. However, the component(s) of a specific folate transport system in erythroid progenitors has not been identified.
During studies with high affinity, specific FBPs isolated from human placental membranes, we raised rabbit antiserum to the purified FBPs and identified the presence of immunologically cross-reactive moieties on mature human erythrocytes (3) . Subsequent ligand binding studies with 3H-and "1C-labeled folates did not detect significant specific radioligand binding to isolated erythrocyte membranes. With the recent synthesis of a stable radioiodinated histamine derivative of folic acid with a specific activity that was 50-fold higher than previously available radiolabeled folates, as well as the development of a sensitive and specific radioimmunoassay for placental folate receptors and related high affinity specific FBPs (6), it was possible to extend earlier studies of FBPs on intact erythrocytes. We found (4, 5) that FBPs from purified membranes of circulating human erythrocytes possessed similar biochemical characteristics with respect to ligand binding, antigenic identities, molecular weights, external orientation, and hydrophobicity as physiological KB cell folate receptors (2, 11) . However, the number of functional FBPs that participated in the binding and internalization of folates in erythrocytes was < 1% of the total number of immunoreactive FBPs per cell. Furthermore, folate uptake in circulating erythrocytes was four to six orders of magnitude less than that identified in KB cells. Taken together, these findings suggested that the existing FBPs in circulating erythrocytes were probably vestigal remnants of a prior functional folate transport system in actively dividing erythroid precursors within the bone marrow.2 With this background, we attempted this study to determine ifspecific FBPs were functionally important in the proliferation and differentiation of erythroid progenitor cells.
With the advent of methods to specifically assay for human bone marrow erythroid progenitor cells in vitro, we reasoned that the FBPs on the surface of primitive erythroid lineage cells could be perturbed by antihuman PFR antiserum. This hypothesis was based on our earlier studies (4, 5, Sa), which showed (i) cross-reactive material to PFR on circulating erythrocytes; (ii) immunoprecipitation of radioligand-bound solubilized erythrocyte FBP with antihuman PFR antiserum (4) ; and (iii) the demonstration that antihuman PFR antiserum could inhibit the binding and internalization of radiolabeled folate in circulating erythrocytes and sealed-right-side-out ghosts (5) . The results from the present studies (Table I and Fig. 1 ) suggested that antihuman PFR antiserum enhanced BFU-E cloning efficiency as well as increasing the number of cells comprising individual erythroid bursts. The cells comprising the bursts were also megaloblastic by morphologic criteria ( Fig. 2 and Table I ). Significantly, these changes were associated with a marked reduction of intracellular folate content in antihuman PFR antiserum-treated cells, where -onethird the amount of folate was accumulated intracellularly as compared with control cells. Therefore, it is likely that folatedeficient megaloblastic erythropoiesis was induced in vitro by antihuman PFR antiserum.
It is important to emphasize that the method to quantitate endogenous folate has definite limitations in that it relies solely on the ability of (released) intracellular folates to displace 12511 labeled folic acid (histamine derivative) from bovine FBP. Since various folates differ significantly in their affinity for FBPs (3, 7, 10) , it follows that the assay will identify only those folates (like 5-methyltetrahydrofolate) having high affinity for FBPs. Conversely, other folates (e.g., 5-formyltetrahydrofolate) having lower affinity for FBPs will not be measured even if they were present in significantly increased concentrations intracellularly. Moreover, since the forms of folates in erythroid precursor cells during in vitro erythropoiesis is not known, a decrease in measured endogenous intracellular folate (in antiserum-treated cells as compared with preimmune serum-treated cells) may be interpreted as being due 
